Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00844272
What this trial is testing

Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment

Who this might be right for
Intravenous Drug AbuseChronic Hepatitis C
Universitätsklinikum Hamburg-Eppendorf 189
Testing effectiveness (Phase 2)Study completedNCT00418639
What this trial is testing

Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 50
Large-scale testing (Phase 3)Study completedNCT03186365
What this trial is testing

8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 82
Not applicableStudy completedNCT02592057
What this trial is testing

Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

Who this might be right for
Hepatitis C Virus
Gilead Sciences 532
Post-approval studies (Phase 4)Study completedNCT00553930
What this trial is testing

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Who this might be right for
Hepatitis C, ChronicHIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 71
Large-scale testing (Phase 3)UnknownNCT02646111
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures

Who this might be right for
Hepatitis C
Tel-Aviv Sourasky Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT01278134
What this trial is testing

RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 170
Not applicableStudy completedNCT03693586
What this trial is testing

Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis

Who this might be right for
Chronic Hepatitis cVasculitis
Hospital General de Mexico 1,000
Testing effectiveness (Phase 2)Study completedNCT01355289
What this trial is testing

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

Who this might be right for
Thrombocytopenia
Eisai Inc. 65
Testing effectiveness (Phase 2)Study completedNCT02202980
What this trial is testing

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 273
Testing effectiveness (Phase 2)Study completedNCT01170962
What this trial is testing

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 512
Early research (Phase 1)Study completedNCT01371162
What this trial is testing

RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 42
Testing effectiveness (Phase 2)Study completedNCT00601770
What this trial is testing

Virological Response Study of the HCV Vaccine IC41

Who this might be right for
Chronic Hepatitis C
Valneva Austria GmbH 71
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Not applicableStudy completedNCT00709059
What this trial is testing

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 538
Large-scale testing (Phase 3)Study completedNCT02660905
What this trial is testing

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Who this might be right for
Human Immunodeficiency VirusHepatitis C, Chronic
Ottawa Hospital Research Institute 25
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Large-scale testing (Phase 3)Study completedNCT02346721
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Next Page